Sunitinib Malate in Refractory Germ Cell Tumors

Clinical trial NCT00912912 · TERMINATED

Trial details

NCT number: NCT00912912
Sponsor: M.D. Anderson Cancer Center
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Genitourinary Disease

Start date: 2009-05-01
Primary completion: 2014-12-01
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.